Vivitide Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 72

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 3

  • Investments
  • 2

Vivitide General Information

Description

Manufacturer of peptides and polyclonal antibodies intended for drug, vaccine and diagnostic development organizations. The company offers peptide arrays, catalog peptides, novel amino acids, amino acid derivatives, small molecule organic synthesis and resins for the treatment of cancer, diabetes, obesity, infection and Human Immunodeficiency Virus (HIV), providing quality and customized products.

Contact Information

Website
www.vivitide.com
Formerly Known As
New England Peptide
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Acquirer
Biosynth
Primary Office
  • 65 Zub Lane
  • Gardner, MA 01440
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vivitide Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Vivitide‘s full profile, request access.

Request a free trial

Vivitide Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of peptides and polyclonal antibodies intended for drug, vaccine and diagnostic development organizations.
Biotechnology
Gardner, MA
72 As of 2022
000000000000

000 00

m ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incid
00000 00000000000000
San Jose, CA
000 As of 0000
0000 0000-00-00
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vivitide Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
000 0000000000 Formerly VC-backed San Jose, CA 000 000000&0
You’re viewing 1 of 1 competitors. Get the full list »

Vivitide Patents

  • 7

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 1

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Vivitide Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2688904-B1 Polypeptides with affinity for heat shock proteins (hsps) and hsp associated complexes (hacs) and their use in diagnosis and therapy Active 21-Mar-2011 0000000000
CA-2830772-A1 Polypeptides with affinity for heat shock proteins (hsps) and hsp associated complexes (hacs) and their use in diagnosis and therapy Active 21-Mar-2011 0000000000
CA-2830772-C Polypeptides with affinity for heat shock proteins (hsps) and hsp associated complexes (hacs) and their use in diagnosis and therapy Active 21-Mar-2011 0000000000
EP-2688904-A1 Polypeptides with affinity for heat shock proteins (hsps) and hsp associated complexes (hacs) and their use in diagnosis and therapy Active 21-Mar-2011 0000000000
EP-2688904-A4 Polypeptides with affinity for heat shock proteins (hsps) and hsp associated complexes (hacs) and their use in diagnosis and therapy Active 21-Mar-2011 C07K14/435 0
To view Vivitide’s complete patent history, request access »

Vivitide Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vivitide Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Vivitide‘s full profile, request access.

Request a free trial

Vivitide Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 0000 12-Dec-2019 0000000000 Biotechnology 000000 00
Sigma-Genosys 01-Jan-2008 Buyout/LBO Biotechnology
To view Vivitide’s complete investments history, request access »